BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kovach SJ, Sitzmann JV, Mckillop IH. Inhibition of alcohol dehydrogenase blocks enhanced Gi-protein expression following ethanol treatment in experimental hepatocellular carcinoma in vitro: . European Journal of Gastroenterology & Hepatology 2001;13:1209-16. [DOI: 10.1097/00042737-200110000-00014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
Number Citing Articles
1 de Medeiros IC, de Lima JG. Is nonalcoholic fatty liver disease an endogenous alcoholic fatty liver disease? – A mechanistic hypothesis. Medical Hypotheses 2015;85:148-52. [DOI: 10.1016/j.mehy.2015.04.021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
2 Boyle M, Masson S, Anstee QM. The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease. Journal of Hepatology 2018;68:251-67. [DOI: 10.1016/j.jhep.2017.11.006] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 13.0] [Reference Citation Analysis]
3 Brandon-Warner E, Sugg JA, Schrum LW, McKillop IH. Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma. Cancer Lett 2010;291:120-9. [PMID: 19900758 DOI: 10.1016/j.canlet.2009.10.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
4 Aroor AR, Shukla SD. MAP kinase signaling in diverse effects of ethanol. Life Sci. 2004;74:2339-2364. [PMID: 15027449 DOI: 10.1016/j.lfs.2003.11.001] [Cited by in Crossref: 143] [Cited by in F6Publishing: 143] [Article Influence: 7.9] [Reference Citation Analysis]